Physician profile
Megan C Mcdevitt
NPI 1255733051
$1,565.30
in general payments reported to CMS, 2019-2025
21 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $348 · 2023: $484 · 2024: $281 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $316.18 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $188.39 | 2021-2024 | |
| Amgen INC. | $174.83 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.01 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $118.23 | 2023-2025 | Eliquis, Camzyos |
| Pfizer INC. | $92.50 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $61.62 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $61.26 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $59.23 | 2021-2022 | |
| Esperion Therapeutics, INC. | $54.15 | 2022-2024 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $40.35 | 2021-2023 | Arcalyst |
| Scpharmaceuticals INC. | $33.97 | 2023-2024 | |
| Amarin Pharma, INC. | $32.66 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $29.09 | 2024 | Verquvo |
| Stryker Corporation | $24.89 | 2023 | Cartiva Synthetic Cartilage Implant, Augment Injectable, Infinity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $24.79 | 2023 | Onpattro |
| Atricure, INC. | $22.19 | 2022 | |
| Tactile Systems Technology INC | $19.66 | 2023 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $19.52 | 2023 | Linq II |
| Regeneron Healthcare Solutions, INC. | $17.57 | 2023 | Evkeeza |
| Janssen Pharmaceuticals, INC | $14.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Mcdevitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.